AF has been shown to suppress inflammation via inhibiting NF‐κB/NLRP3 and PI3K/AKT pathways in other disease models, and to alleviate neuroinflammation through the PGK1/Nrf2/HO‐1 pathway [29–31]. Here, NFKB1 is linked to atrial fibrillation.